Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA03 - Clinomics and Genomics
- 10:30 - 12:00
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Heather A Wakelee, Wilfried Ernst Erich Eberhardt
-
+
MA03.06 - Efficacy Results of Selective AXL Inhibitor Bemcentinib with Pembrolizumab Following Chemotherapy in Patients with NSCLC
11:05 - 11:10 | Presenter: Enriqueta Felip | Author(s): Paal Brunsvig, Åslaug Helland, Nuria Viñolas, Santiago Ponce Aix, Enric Carcereny, Manuel Dómine, Jose Manuel Trigo Perez, Edurne Arriola, Rosario Garcia Campelo, James Spicer, Jonathan Robert Thompson, Ana Laura Ortega Granados, Robert J. Holt, Dominic Smethurst, James B. Lorens, Muhammad Shoaib, Abdul Siddiqui, Julia Schoelermann, Katherine Lorens, Emmett V. Schmidt, Michael Jon Chisamore, Matthew Krebs
- Abstract
Loading...
-
+
EP1.01 - Advanced NSCLC
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
EP1.01-28 - Real World Use of Afatinib in NSCLC EGFRm+ Patients Outside Clinical Trials: A FAETT Experience
08:00 - 08:00 | Presenter: Inmaculada Ramos García | Author(s): Amparo Sánchez, Ana Laura Ortega, José Fuentes Pradera, Manuel Cobo, Mª Ángeles Moreno, Isidoro Barneto, Sofía Ruiz, Inmaculada Fernández, Teresa García, Fatima Toscano, Jose Manuel Trigo Perez
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-72 - A Phase II Study of Selective AXL Inhibitor Bemcentinib and Pembrolizumab in Patients with NSCLC Refractory to Anti-PD(L)1
09:45 - 09:45 | Presenter: Matthew Krebs | Author(s): Paal Brunsvig, Åslaug Helland, Nuria Viñolas, Santiago Ponce Aix, Enric Carcereny, Manuel Dómine, Jose Manuel Trigo Perez, Edurne Arriola, Rosario Garcia Campelo, James Spicer, Jonathan Robert Thompson, Ana Laura Ortega Granados, Robert J. Holt, Dominic Smethurst, James B. Lorens, Muhammad Shoaib, Abdul Siddiqui, Julia Schoelermann, Katherine Lorens, Emmett V. Schmidt, Michael Jon Chisamore, Enriqueta Felip
- Abstract
Loading...
-
+
P1.12 - Small Cell Lung Cancer/NET
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
-
+
P1.12-03 - Antitumor Activity of Single Agent Lurbinectedin in Patients with Relapsed SCLC Occurring ≥30 Days After Last Platinum Dose
09:45 - 09:45 | Presenter: Jose Manuel Trigo Perez | Author(s): Vivek Subbiah, Benjamin Besse, Victor Moreno, Rafael López, M.Angeles Sala, Santiago Ponce, Cristian Fernendez, Antonio Nieto, Carmen Kahatt, Ali Zeaiter, Khalil Zaman, Valentina Boni, Jennifer Arrondeau, Marta Martinez, Jean Pierre Delord, Ahmad Awada, Rebeca Kristeleit, Fede Longo, John Sarantopoulos, Maria Jesús Rubio, Antonio Anton, Luciano Wannesson, Javier Valdivia, Geoffrey Shappiro, Víctor Villalobos, Armando Santoro, Manolo D'Arcangelo, Luis Aparicio, Luis Paz-Ares
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-12 - A Phase I/II Trial of IO102 and Pembrolizumab With/Without Chemotherapy as First-line Treatment of Metastatic NSCLC
10:15 - 10:15 | Presenter: Mariano Provencio | Author(s): James Spicer, Pilar Garrido, Jose Manuel Trigo Perez, Santiago Viteri, Joaquim Bosch-Barrera, Amelia Insa, Enriqueta Felip, Javier De Castro Carpeno, Elisabeth Coart, Emmett Schmidt, Anita Vedel Christiansen, Mads Hald Andersen, Mai-Britt Zocca, Eva Ehrnrooth, Luis Paz-Aras
- Abstract
Loading...